Hasil untuk "Medicine"

A. Caplan, S. Bruder

Joanne M. Meyer, G. Ginsburg

J. Karlberg

P. Siegel

A. MacLennan, D. Wilson, A. Taylor

J. Tintinalli, R. Krome, E. Ruiz

E. Ernst

F. Mettler, Mythreyi Bhargavan, K. Faulkner et al.

J. Eggenschwiler, Leopold von Balthazar, Bianca Stritt et al.

L. Hood, S. Friend

P. Pound, N. Britten, M. Morgan et al.

R. Mirnezami, J. Nicholson, A. Darzi

J. Shih, D. Krusienski, J. Wolpaw

W. Westcott

M. Graber

A wide variety of research studies suggest that breakdowns in the diagnostic process result in a staggering toll of harm and patient deaths. These include autopsy studies, case reviews, surveys of patient and physicians, voluntary reporting systems, using standardised patients, second reviews, diagnostic testing audits and closed claims reviews. Although these different approaches provide important information and unique insights regarding diagnostic errors, each has limitations and none is well suited to establishing the incidence of diagnostic error in actual practice, or the aggregate rate of error and harm. We argue that being able to measure the incidence of diagnostic error is essential to enable research studies on diagnostic error, and to initiate quality improvement projects aimed at reducing the risk of error and harm. Three approaches appear most promising in this regard: (1) using ‘trigger tools’ to identify from electronic health records cases at high risk for diagnostic error; (2) using standardised patients (secret shoppers) to study the rate of error in practice; (3) encouraging both patients and physicians to voluntarily report errors they encounter, and facilitating this process.

T. Manolio, R. Chisholm, B. Ozenberger et al.

Although the potential for genomics to contribute to clinical care has long been anticipated, the pace of defining the risks and benefits of incorporating genomic findings into medical practice has been relatively slow. Several institutions have recently begun genomic medicine programs, encountering many of the same obstacles and developing the same solutions, often independently. Recognizing that successful early experiences can inform subsequent efforts, the National Human Genome Research Institute brought together a number of these groups to describe their ongoing projects and challenges, identify common infrastructure and research needs, and outline an implementation framework for investigating and introducing similar programs elsewhere. Chief among the challenges were limited evidence and consensus on which genomic variants were medically relevant; lack of reimbursement for genomically driven interventions; and burden to patients and clinicians of assaying, reporting, intervening, and following up genomic findings. Key infrastructure needs included an openly accessible knowledge base capturing sequence variants and their phenotypic associations and a framework for defining and cataloging clinically actionable variants. Multiple institutions are actively engaged in using genomic information in clinical care. Much of this work is being done in isolation and would benefit from more structured collaboration and sharing of best practices.Genet Med 2013:15(4):258–267

Ruichao Xue, Zhao Fang, Meixia Zhang et al.

As an alternative to modern western medicine, Traditional Chinese Medicine (TCM) is receiving increasingly attention worldwide. Great efforts have been paid to TCM’s modernization, which tries to bridge the gap between TCM and modern western medicine. As TCM and modern western medicine share a common aspect at molecular level that the compound(s) perturb human’s dysfunction network and restore human normal physiological condition, the relationship between compounds (in herb, refer to ingredients) and their targets (proteins) should be the key factor to connect TCM and modern medicine. Accordingly, we construct this Traditional Chinese Medicine Integrated Database (TCMID, http://www.megabionet.org/tcmid/), which records TCM-related information collected from different resources and through text-mining method. To enlarge the scope of the TCMID, the data have been linked to common drug and disease databases, including Drugbank, OMIM and PubChem. Currently, our TCMID contains ∼47 000 prescriptions, 8159 herbs, 25 210 compounds, 6828 drugs, 3791 diseases and 17 521 related targets, which is the largest data set for related field. Our web-based software displays a network for integrative relationships between herbs and their treated diseases, the active ingredients and their targets, which will facilitate the study of combination therapy and understanding of the underlying mechanisms for TCM at molecular level.

Anran Li, Yuanyuan Chen, Wenjun Long et al.

Large language models (LLMs) have demonstrated strong performance on medical benchmarks, including question answering and diagnosis. To enable their use in clinical settings, LLMs are typically further adapted through continued pretraining or post-training using clinical data. However, most medical LLMs are trained on data from a single institution, which faces limitations in generalizability and safety in heterogeneous systems. Federated learning (FL) is a promising solution for enabling collaborative model development across healthcare institutions. Yet applying FL to LLMs in medicine remains fundamentally limited. First, conventional FL requires transmitting the full model during each communication round, which becomes impractical for multi-billion-parameter LLMs given the limited computational resources. Second, many FL algorithms implicitly assume data homogeneity, whereas real-world clinical data are highly heterogeneous across patients, diseases, and institutional practices. We introduce the model-agnostic and parameter-efficient federated learning framework for adapting LLMs to medical applications. Fed-MedLoRA transmits only low-rank adapter parameters, reducing communication and computation overhead, while Fed-MedLoRA+ further incorporates adaptive, data-aware aggregation to improve convergence under cross-site heterogeneity. We apply the framework to clinical information extraction (IE), which transforms patient narratives into structured medical entities and relations. Accuracy was assessed across five patient cohorts through comparisons with BERT models, and LLaMA-3 and DeepSeek-R1, GPT-4o models. Evaluation settings included (1) in-domain training and testing, (2) external validation on independent cohorts, and (3) a low-resource new-site adaptation scenario using real-world clinical notes from the Yale New Haven Health System.

Jiatong Han

Traditional Chinese Medicine (TCM) theory is built on imagistic thinking, in which medical principles and diagnostic and therapeutic logic are structured through metaphor and metonymy. However, existing English translations largely rely on literal rendering, making it difficult for target-language readers to reconstruct the underlying conceptual networks and apply them in clinical practice. This study adopted a human-in-the-loop (HITL) framework and selected four passages from the medical canon Huangdi Neijing that are fundamental in theory. Through prompt-based cognitive scaffolding, DeepSeek V3.1 was guided to identify metaphor and metonymy in the source text and convey the theory in translation. In the evaluation stage, ChatGPT 5 Pro and Gemini 2.5 Pro were instructed by prompts to simulate three types of real-world readers. Human translations, baseline model translations, and prompt-adjusted translations were scored by the simulated readers across five cognitive dimensions, followed by structured interviews and Interpretative Phenomenological Analysis (IPA). Results show that the prompt-adjusted LLM translations perform best across all five dimensions, with high cross-model and cross-role consistency. The interview themes reveal differences between human and machine translation, effective strategies for metaphor and metonymy transfer, and readers' cognitive preferences. This study provides a cognitive, efficient, and replicable HITL methodological pathway for the translation of ancient, concept-dense texts such as TCM.

Mengzhou Sun, Sendong Zhao, Jianyu Chen et al.

Evidence-based medicine (EBM) holds a crucial role in clinical application. Given suitable medical articles, doctors effectively reduce the incidence of misdiagnoses. Researchers find it efficient to use large language models (LLMs) techniques like RAG for EBM tasks. However, the EBM maintains stringent requirements for evidence, and RAG applications in EBM struggle to efficiently distinguish high-quality evidence. Therefore, inspired by the meta-analysis used in EBM, we provide a new method to re-rank and filter the medical evidence. This method presents multiple principles to filter the best evidence for LLMs to diagnose. We employ a combination of several EBM methods to emulate the meta-analysis, which includes reliability analysis, heterogeneity analysis, and extrapolation analysis. These processes allow the users to retrieve the best medical evidence for the LLMs. Ultimately, we evaluate these high-quality articles and show an accuracy improvement of up to 11.4% in our experiments and results. Our method successfully enables RAG to extract higher-quality and more reliable evidence from the PubMed dataset. This work can reduce the infusion of incorrect knowledge into responses and help users receive more effective replies.